Filing Details

Accession Number:
0000711377-16-000079
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-11 08:37:45
Reporting Period:
2016-08-09
Filing Date:
2016-08-11
Accepted Time:
2016-08-11 08:37:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-09 6,068 $36.07 903,850 No 4 M Direct
Common Stock Disposition 2016-08-09 6,068 $55.60 897,782 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2016-08-09 6,068 $0.00 6,068 $36.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
296,502 2018-08-30 No 4 M Direct
Footnotes
  1. Options were granted 8/30/2013, have 5 year lives, and vest in five equal annual installments on the anniversary date of the grant